trial · primary record
Placebo
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2028-02-14 |
| Primary endpoint | Number of Participants With Treatment-emergent Adverse Events (TEAEs) |
| Registry ID | NCT07160608 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:55.516Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07160608
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound